Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M J Moro

Showing results (31-40 of 59) with videos related to

Pageof 6
Sort By:
Blood|August 1, 1988
Leukemias with megakaryoblastic involvement: clinical, hematologic, and immunologic characteristicsJ F San Miguel, M Gonzalez, M C Cañizo, et al.
British Journal of Haematology|December 12, 2001
Continuous oral cytarabine ocfosfate with interferon-alpha-2b for patients with newly diagnosed chronic myeloid leukaemia: a pilot studyM C del Cañizo, M P Fisac, J Galende, et al.
Sangre|June 1, 1992
[Utility of the examination of plasma-cell morphology in the study of multiple myeloma]M J Moro, J A Portero, A Gascón, et al.
British Journal of Haematology|February 1, 1991
Immunophenotypic heterogeneity of multiple myeloma: influence on the biology and clinical course of the disease. Castellano-Leones (Spain) Cooperative Group for the Study of Monoclonal GammopathiesJ F San Miguel, M González, A Gascón, et al.
British Journal of Haematology|March 1, 1992
Lymphoid subsets and prognostic factors in multiple myeloma. Cooperative Group for the Study of Monoclonal GammopathiesJ F San Miguel, M González, A Gascón, et al.
American Journal of Hematology|February 1, 1992
Increased expression of natural-killer-associated and activation antigens in multiple myelomaM Gonzalez, J F San Miguel, A Gascon, et al.
British Journal of Haematology|October 16, 1999
High-sensitive immunophenotyping and DNA ploidy studies for the investigation of minimal residual disease in multiple myelomaJ Almeida, A Orfao, M Ocqueteau, et al.
Blut|June 1, 1990
A randomized multicentric study comparing alternating combination chemotherapy (VCMP/VBAP) and melphalan-prednisone in multiple myelomaJ Bladé, J San Miguel, A Alcalá, et al.
Annals of Hematology|November 22, 1997
Functional expression of MDR-1 in acute myeloid leukemia: correlation with the clinical-biological, immunophenotypical, and prognostic disease characteristicsA Martínez, J F San Miguel, B Valverde, et al.
Revista Espanola De Enfermedades Digestivas|January 20, 2010
[An 84-year-old woman who presents with edema in lower limbs]S Sanz-Baena, G Pérez-Martín, E Berrocal-Valencia, et al.
Pageof 6

Showing results (31-40 of 59) with videos related to

Sort By:
Pageof 6
Blood|August 1, 1988
Leukemias with megakaryoblastic involvement: clinical, hematologic, and immunologic characteristicsJ F San Miguel, M Gonzalez, M C Cañizo, et al.
British Journal of Haematology|December 12, 2001
Continuous oral cytarabine ocfosfate with interferon-alpha-2b for patients with newly diagnosed chronic myeloid leukaemia: a pilot studyM C del Cañizo, M P Fisac, J Galende, et al.
Sangre|June 1, 1992
[Utility of the examination of plasma-cell morphology in the study of multiple myeloma]M J Moro, J A Portero, A Gascón, et al.
British Journal of Haematology|February 1, 1991
Immunophenotypic heterogeneity of multiple myeloma: influence on the biology and clinical course of the disease. Castellano-Leones (Spain) Cooperative Group for the Study of Monoclonal GammopathiesJ F San Miguel, M González, A Gascón, et al.
British Journal of Haematology|March 1, 1992
Lymphoid subsets and prognostic factors in multiple myeloma. Cooperative Group for the Study of Monoclonal GammopathiesJ F San Miguel, M González, A Gascón, et al.
American Journal of Hematology|February 1, 1992
Increased expression of natural-killer-associated and activation antigens in multiple myelomaM Gonzalez, J F San Miguel, A Gascon, et al.
British Journal of Haematology|October 16, 1999
High-sensitive immunophenotyping and DNA ploidy studies for the investigation of minimal residual disease in multiple myelomaJ Almeida, A Orfao, M Ocqueteau, et al.
Blut|June 1, 1990
A randomized multicentric study comparing alternating combination chemotherapy (VCMP/VBAP) and melphalan-prednisone in multiple myelomaJ Bladé, J San Miguel, A Alcalá, et al.
Annals of Hematology|November 22, 1997
Functional expression of MDR-1 in acute myeloid leukemia: correlation with the clinical-biological, immunophenotypical, and prognostic disease characteristicsA Martínez, J F San Miguel, B Valverde, et al.
Revista Espanola De Enfermedades Digestivas|January 20, 2010
[An 84-year-old woman who presents with edema in lower limbs]S Sanz-Baena, G Pérez-Martín, E Berrocal-Valencia, et al.
Pageof 6